InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Baluch Khoso. Insider active across 2 companies, notably Processa Pharmaceuticals, Inc.. Aggregated, 11 reports have been logged. Breakdown: 3 buys · 1 sell. Total volume traded: €10k. History available since 9 February 2023. The latest transaction was disclosed on 31 March 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Baluch Khoso is a declarant and has 11 filings in total. In the sampled recent filings from 2023-02-10 to 2026-06-30, the reported buy and sell amounts are EUR 7078 and EUR 2454, and the most common transaction nature is Attribution. He is a director of Longeveron Inc. and Processa Pharmaceuticals, Inc.